Position in VTRS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$13,180
+$2,035 QoQ
Shares Held
830
+0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#743
of 1,016 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026New England Capital Financial Advisors LLC holds $14,985 across 3 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (88.0% of the industry book) .
All Filings in VTRS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,180 | 830 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $11,145 | 825 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $10,184 | 818 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $8,028 | 811 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $7,376 | 826 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $6,924 | 795 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $9,785 | 786 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $9,044 | 779 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $8,599 | 809 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $9,575 | 802 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $8,609 | 795 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $7,759 | 787 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $7,774 | 779 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $7,417 | 771 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $8,725 | 784 | Shares | Sole | 2023-02-06 | |
| No filing history on record for this holder in this stock. | ||||||